Patients with advanced lung cancer and their caregivers are confronted with a complex situation as their disease-related burden comprises physical, psychosocial, and spiritual needs. During the illness trajectory with limited prognosis, they are exposed to different multidisciplinary healthcare settings and providers that challenge the continuity and coordination of care. Additionally, decision-making between active cancer treatment and end-of-life care constitutes a continuous balancing act. Several studies have shown that early integration of palliative care and adequate advance care planning improve quality of life and satisfaction with care. For this strategy, the communication skills of healthcare providers and interprofessional collaboration should be strengthened. A longitudinally structured communication approach along pivotal milestones of the disease can empower patients by facilitating coping and prognostic awareness, and achieve early integration of palliative care and advance care planning. Good interprofessional collaboration and communication lead to better coordination and continuity of care.

Keywords:
Communication, Advanced lung cancer, Early palliative care, Advance care planning
1.
Aubin M, Vézina L, Verreault R, Fillion L, Hudon E, Lehmann F, Leduc Y, Bergeron R, Reinharz D, Morin D: Family physician involvement in cancer care follow-up: the experience of a cohort of patients with lung cancer. Ann Fam Med 2010;8:526-532.
2.
Fleissig A, Jenkins V, Catt S, Fallowfield L: Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol 2006;7:935-943.
3.
Gagliardi AR, Dobrow MJ, Wright FC: How can we improve cancer care? A review of interprofessional collaboration models and their use in clinical management. Surg Oncol 2011;20:146-154.
4.
Oechsle K, Goerth K, Bokemeyer C, Mehnert A: Symptom burden in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians. Support Care Cancer 2013;21:1955-1962.
5.
Baile WF, Palmer JL, Bruera E, Parker P: Assessment of palliative care cancer patients' most important concerns. Support Care Cancer 2011;19:475-481.
6.
Hack TF, Degner LF, Parker PA: The communication goals and needs of cancer patients: a review. Psychooncology 2005;14:831-845.
7.
Ho A, Jameson K and Pavlish C: An exploratory study of interprofessional collaboration in end-of-life decision-making beyond palliative care settings. J Interprof Care 2016;30:795-803.
8.
Shanafelt T, Dyrbye L: Oncologist burnout: causes, consequences, and responses. J Clin Oncol 2012;30:1235-1241.
9.
Block SD: Medical education in end-of-life care: the status of reform. J Palliat Med 2002;5:243-248.
10.
Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP: SPIKES - a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 2000;5:302-311.
11.
Fischer G, Tulsky J, Arnold R: Communicating a poor prognosis; in Portenoy R, Bruera E (eds): Topics in Palliative Care. New York, Oxford University Press, 2000, pp. 75-94.
12.
Moore PM, Rivera Mercado S, Grez Artiques M, Lawrie TA: Communication skills training for healthcare professionals working with people who have cancer. Cochrane Database Syst Rev 2013;3:CD003751.
13.
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith T: Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2017;35:96-112.
14.
Pfeil TA, Laryionava K, Reiter-Theil S, Hiddemann W, Winkler EC: What keeps oncologists from addressing palliative care early on with incurable cancer patients? An active stance seems key. Oncologist 2015;20:56-61.
15.
Hancock K, Clayton JM, Parker SM, Wal der S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MHN: Truthtelling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliat Med 2007;21:507-517.
16.
Bernacki RE, Block SD: Communication about serious illness care: a review and synthesis of best practices. JAMA Intern Med 2014;174:1994-2003.
17.
Peppercorn JM, Smith TJ, Helft PR, DeBono DJ, Berry SR, Wollins DS, Hayes DM, Von Roenn JH, Schnipper LE: American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 2011;29:755-760.
18.
Barth J, Lannen P: Efficacy of communication skills training courses in oncology: a systematic review and meta-analysis. Ann Oncol 2011;22:1030-1040.
19.
Nehls W, Gabrijel S, Kiss A, Delis S, Black NB, Kollmeier J, Koch A, Bauer T: Communication skills training significantly improves lung cancer patient's understanding. J Palliat Care Med 2014;4:182.
20.
Uitterhoeve RJ, Bensing JM, Grol RP, Demulder PH, Van Achterberg T: The effect of communication skills training on patient outcomes in cancer care: a systematic review of the literature. Eur J Cancer Care 2010;19:442-457.
21.
Back AL, Arnold RM, Baile WF, Fryer-Edwards KA, Alexander SC, Barley GE, Gooley TA, Tulsky JA: Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med 2007;167:453-460.
22.
Goelz T, Wuensch A, Stubenrauch S, Ihorst G, de Figueiredo M, Bertz H, Wirsching M, Fritzsche K: Specific training program improves oncologists' palliative care communication skills in a randomized controlled trial. J Clin Oncol 2011;29:3402-3407.
23.
Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA: Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 2015;33:1438-1445.
24.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-742.
25.
Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C: Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014;383:1721-1730.
26.
Hoerger M, Greer JA, Jackson VA, Park ER, Pirl WF, El-Jawahri A, Gallagher ER, Hagan T, Jacobsen J, Perry LM, Temel JS: Defining the elements of early palliative care that are associated with patient-reported outcomes and the delivery of end-of-life care. J Clin Oncol 2018;36:1096-1102.
27.
Hui D, Bruera E: Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol 2016;13:159-171.
28.
Rietjens JAC, Sudore RL, Connolly M, van Velden JJ, Drickamer MA, Droger M, van der Heide A, Heyland DK, Houttekier D, Janssen DJA, Orsi L, Payne S, Seymour J, Jox RJ, Korfage IJ; on behalf of the European Association for Palliative Care: Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol 2017;18:e543-551.
29.
Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A: The effects of advance care planning on end-of-life care: a systematic review. Palliat Med 2014;28:1000-1025.
30.
Temel JS, Gainor JF, Sullivan RJ, Greer JA: Keeping expectations in check with immune checkpoint inhibitors. J Clin Oncol 2018;36:1654-1657.
31.
Jenkins V, Fallowfield L, Saul J: Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001;84:48-51.
32.
Rumpold T, Lütgendorf-Caucig C, Jagsch R, Dieckmann K, Watzke H, Pötter R, Kirchheiner K: Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer. Strahlenther Onkol 2015;191:549-556.
33.
Temel JS, Greer JA, Admane S, Gallagher ER, Jackson VA, Lynch TJ, Lennes IT, Dahlin CM, Pirl WF: Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 2011;29:2319-2326.
34.
Jackson VA, Jacobsen J, Greer JA, Pirl WF, Temel JS, Black AL: The cultivation of prognostic awareness through the provision of early palliative care in the ambulatory setting: a communication guide. J Palliat Med 2013;16:894-900.
35.
Murray SA, Kendall M, Boyd K, Sheikh A: Illness trajectories and palliative care. BMJ 2005;330:1007-1011.
36.
Tessmer G, Zaba O, Grohe C: (Concept of a forward-looking communication in the palliative treatment of patients with pneumological-oncological diseases prospective). Pneumologie 2011;65:503-509.
37.
Siegle A, Villalobos M, Bossert J, Krug K, Hagelskamp L, Krisam J, Handtke V, Deis N, Jünger J, Wensing M, Thomas M: The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial. Trials 2018;19:438.
38.
Hui D, Kim SH, Roquemore J, Dev R, Chisholm G, Bruera E: Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer 2014;120:1743-1749.
39.
Gordon-Lubitz RJ: Risk communication: problems of presentation and understanding. JAMA 2003;289:95.
40.
Wills CE, Holmes-Rovner M: Patient comprehension of information for shared treatment decision making: state of the art and future directions. Patient Educ Couns 2003;50:285-290.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.